Literature DB >> 28463105

Prevalence of HPV in Adults Aged 18-69: United States, 2011-2014.

Geraldine McQuillan, Deanna Kruszon-Moran, Lauri E Markowitz, Elizabeth R Unger, Ryne Paulose-Ram.   

Abstract

KEY
FINDINGS: Data from the National Health and Nutrition Examination Survey Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States (1). Some HPV types can cause genital warts and are considered low risk, with a small chance for causing cancer. Other types are considered high risk, causing cancer in different areas of the body including the cervix and vagina in women, penis in men, and anus and oropharynx in both men and women (2). This report provides the most recent national estimates of oral HPV prevalence among adults aged 18-69 from the National Health and Nutrition Examination Survey (NHANES) 2011-2014, as well as prevalence of genital HPV among adults aged 18-59 from NHANES 2013-2014. Estimates of any HPV (37 types tested) as well as high-risk HPV (14 of the 37 types) are provided. All material appearing in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.

Entities:  

Keywords:  human papillomavirus • NHANES Prevalence of any oral HPV was lowest among non-Hispanic Asian adults and highest among non-Hispanic black adults. ● During 2011-2014; prevalence of any and high-risk genital HPV for adults aged 18-59 was 45.2% and 25.1% in men and 39.9% and 20.4% in women respectively. ● Prevalence of any and high-risk genital HPV was lower among non-Hispanic Asian and higher among non-Hispanic black than both non-Hispanic white and Hispanic men and women.; prevalence of any and high-risk oral HPV was lowest among non-Hispanic Asian adults; any oral HPV was highest among non-Hispanic black adults. ● Prevalence of any and high-risk oral HPV was higher in men than women except for high-risk HPV among Asian adults. ● During 2013-2014; prevalence of any oral human papillomavirus (HPV) for adults aged 18-69 was 7.3%; high-risk HPV was 4.0%. ● Overall

Year:  2017        PMID: 28463105

Source DB:  PubMed          Journal:  NCHS Data Brief        ISSN: 1941-4935


  45 in total

Review 1.  Vaccinations for Anal Squamous Cancer: Current and Emerging Therapies.

Authors:  John Berry; Sean C Glasgow
Journal:  Clin Colon Rectal Surg       Date:  2018-11-02

2.  Human Papillomavirus Vaccination Initiation Among Sexual Orientation Identity and Racial/Ethnic Subgroups of Black and White U.S. Women and Girls: An Intersectional Analysis.

Authors:  Madina Agénor; Ashley E Pérez; Sarah M Peitzmeier; Jennifer Potter; Sonya Borrero
Journal:  J Womens Health (Larchmt)       Date:  2018-06-29       Impact factor: 2.681

3.  A content analysis of HPV related posts on instagram.

Authors:  Corey H Basch; Sarah A MacLean
Journal:  Hum Vaccin Immunother       Date:  2019-01-30       Impact factor: 3.452

4.  Toward a Model of HPV Vaccine Series Completion in Adolescent Hispanic Males: Identifying Mothers' Salient Behavioral, Normative, and Control Beliefs.

Authors:  Angelica M Roncancio; Chakema C Carmack; Kristy K Ward; Sally W Vernon; Becky T Muñoz; Miguel A Cano; Felicity L Cribbs
Journal:  Fam Community Health       Date:  2019 Apr/Jun

5.  Assessing sociodemographic differences in human papillomavirus vaccine impact studies in the United States: a systematic review using narrative synthesis.

Authors:  L R Avni-Singer; A Yakely; S S Sheth; E D Shapiro; L M Niccolai; C R Oliveira
Journal:  Public Health       Date:  2019-11-04       Impact factor: 2.427

6.  Acoustofluidic Salivary Exosome Isolation: A Liquid Biopsy Compatible Approach for Human Papillomavirus-Associated Oropharyngeal Cancer Detection.

Authors:  Zeyu Wang; Feng Li; Joseph Rufo; Chuyi Chen; Shujie Yang; Liang Li; Jinxin Zhang; Jordan Cheng; Yong Kim; Mengxi Wu; Elliot Abemayor; Michael Tu; David Chia; Rachel Spruce; Nikolaos Batis; Hisham Mehanna; David T W Wong; Tony Jun Huang
Journal:  J Mol Diagn       Date:  2020-01       Impact factor: 5.568

7.  Prevalence of Genital Human Papillomavirus Among Sexually Experienced Males and Females Aged 14-59 Years, United States, 2013-2014.

Authors:  Rayleen M Lewis; Lauri E Markowitz; Julia W Gargano; Martin Steinau; Elizabeth R Unger
Journal:  J Infect Dis       Date:  2018-03-05       Impact factor: 5.226

8.  HPV Vaccination Communication Messages, Messengers, and Messaging Strategies.

Authors:  Kathleen B Cartmell; Carlie R Mzik; Beth L Sundstrom; John S Luque; Ashley White; Jennifer Young-Pierce
Journal:  J Cancer Educ       Date:  2019-10       Impact factor: 2.037

9.  Ancillary Benefit of Increased HPV Immunization Rates Following a CBPR Approach to Address Immunization Disparities in Younger Siblings.

Authors:  Tyler Lennon; Constance Gundacker; Melodee Nugent; Pippa Simpson; Norma K Magallanes; Christal West; Earnestine Willis
Journal:  J Community Health       Date:  2019-06

10.  A Mixed-Methods Analysis of Barriers to and Facilitators of Human Papillomavirus Vaccination Among Adolescents in Montana.

Authors:  Sophia R Newcomer; James Caringi; Beth Jones; Emily Coyle; Timothy Schehl; Matthew F Daley
Journal:  Public Health Rep       Date:  2020-09-24       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.